GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » EV-to-Revenue

3D Global Biotech (ROCO:6808) EV-to-Revenue : 81.14 (As of May. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is 3D Global Biotech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, 3D Global Biotech's enterprise value is NT$1,674.26 Mil. 3D Global Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$20.63 Mil. Therefore, 3D Global Biotech's EV-to-Revenue for today is 81.14.

The historical rank and industry rank for 3D Global Biotech's EV-to-Revenue or its related term are showing as below:

ROCO:6808' s EV-to-Revenue Range Over the Past 10 Years
Min: 44.84   Med: 113.54   Max: 228.27
Current: 81.15

During the past 7 years, the highest EV-to-Revenue of 3D Global Biotech was 228.27. The lowest was 44.84. And the median was 113.54.

ROCO:6808's EV-to-Revenue is ranked worse than
82.08% of 1038 companies
in the Biotechnology industry
Industry Median: 7.97 vs ROCO:6808: 81.15

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), 3D Global Biotech's stock price is NT$32.70. 3D Global Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.37. Therefore, 3D Global Biotech's PS Ratio for today is 88.86.


3D Global Biotech EV-to-Revenue Historical Data

The historical data trend for 3D Global Biotech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Global Biotech EV-to-Revenue Chart

3D Global Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - 178.49 174.33 96.06 46.01

3D Global Biotech Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 174.33 - 96.06 - 46.01

Competitive Comparison of 3D Global Biotech's EV-to-Revenue

For the Biotechnology subindustry, 3D Global Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3D Global Biotech's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Global Biotech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where 3D Global Biotech's EV-to-Revenue falls into.



3D Global Biotech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

3D Global Biotech's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1674.255/20.633
=81.14

3D Global Biotech's current Enterprise Value is NT$1,674.26 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 3D Global Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$20.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3D Global Biotech  (ROCO:6808) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

3D Global Biotech's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=32.70/0.368
=88.86

3D Global Biotech's share price for today is NT$32.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.37.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3D Global Biotech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of 3D Global Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


3D Global Biotech (ROCO:6808) Business Description

Traded in Other Exchanges
N/A
Address
No.99, Sec. 1, Xintai 5th Rd, 21st Floor -3, Xizhi District, New Taipei, TWN, 221
3D Global Biotech Inc is engaged in developing reconstruction of human tissues and organs and manufactures customized and personalized high-level medical devices.

3D Global Biotech (ROCO:6808) Headlines

No Headlines